Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HNRNPA1L2 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
mRNA | PSD | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | RNF38 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | FZD3 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | C11orf68 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-07 |
mRNA | ZNF184 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | CNOT6 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
mRNA | RBBP4 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
mRNA | NTN3 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
mRNA | PANK1 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |